Literature DB >> 18177471

Mutations in the familial Mediterranean fever gene of patients with IgA nephropathy and other forms of glomerulonephritis.

O L Kukuy1, J Kopolovic, A Blau, A Ben-David, D Lotan, M Shaked, Y Shinar, D Dinour, P Langevitz, A Livneh.   

Abstract

Glomerulonephritis, particularly IgA nephropathy (IgAN), seems to be more common in familial Mediterranean fever (FMF), an inherited disease caused by mutations in the MEditerranean FeVer gene (MEFV). The present study is aimed to determine, in populations not suffering from FMF, whether carriage of MEFV mutations may modify or precipitate IgAN and other forms of primary glomerulonephritis (PGN). Forty patients with biopsy proven IgAN and 40 with PGN were surveyed for the presence of the three most common MEFV mutations (M694V, V726A and E148Q), using polymerase chain reaction amplification and restriction enzyme analysis. The rate of MEFV mutations in the patients was related to the expected carrier rate in the general population of the same ethnic extraction. The effect of mutation carriage on the disease course was determined in the IgAN patient group. The frequency of MEFV mutations in IgAN or PGN was comparable to that found in ethnically adjusted general population (p = 0.1 and 0.5, respectively). Carriage of mutated MEFV was not associated with the course and severity of the disease or findings in kidney biopsy and urine analysis. In a population, mostly of Jewish extraction, MEFV mutations do not seem to predispose to the development of IgAN and other forms of PGN or affect the phenotype.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18177471     DOI: 10.1111/j.1399-0004.2007.00945.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  2 in total

1.  Frequency of familial Mediterranean fever (MEFV) gene mutations in patients with biopsy-proven primary glomerulonephritis.

Authors:  Can Huzmeli; Ferhan Candan; Gokhan Bagci; Demet Alaygut; Ali Yilmaz; Asim Gedikli; Binnur Bagci; Meryem Timucin; Ilhan Sezgin; Mansur Kayatas
Journal:  Clin Rheumatol       Date:  2017-06-01       Impact factor: 2.980

2.  Less IgA deposits with more severe disease: the immunoclinical paradox in Henoch-Schönlein Purpura with MEFV mutations.

Authors:  Ufuk İlgen; Gökhan Nergizoğlu
Journal:  Clin Rheumatol       Date:  2019-07-17       Impact factor: 2.980

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.